Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-22-019342
Filing Date
2022-07-14
Accepted
2022-07-14 17:15:12
Documents
13
Period of Report
2022-06-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 37992
2 ex3-1.htm EX-3.1 7459
  Complete submission text file 0001493152-22-019342.txt   229044

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE dare-20220623.xsd EX-101.SCH 2977
4 XBRL LABEL FILE dare-20220623_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE dare-20220623_pre.xml EX-101.PRE 22801
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 4825
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36395 | Film No.: 221083606
SIC: 2834 Pharmaceutical Preparations